Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 open-label single-arm study of Prolia in men with osteoporosis in mainland China
ChiCTR2400085597Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jun 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of denosumab in osteoporosis, sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Lumbar spine bone mineral density. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2400085597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085597.